---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-23-000047"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2023-07-06T23:59:59+00:00"
generated_at: "2026-06-13T12:24:12.825547+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Myriad Genetics establishes new $90M asset-based credit facility expandable to $115M

## Summary
- New $90M ABL Facility with option to increase by $25M to $115M; matures June 30, 2026.
- Lenders: JPMorgan Chase (admin agent), Wells Fargo, Bank of America; secured by substantially all assets.
- Proceeds for working capital, general corporate purposes, and refinancing existing debt.
- Interest rate options: ABR plus 1.00%-1.50% or Term SOFR plus 2.00%-2.50% based on unused availability.
- Replaces prior credit facility; CEO Paul Diaz cites added financial flexibility for growth.

## SEC filing metadata
- accession: 0000899923-23-000047
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2023-07-06T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992323000047/0000899923-23-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992323000047/mygn-20230630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-23-000047
- JSON: https://secwatch.observer/filing/0000899923-23-000047.json
- Plain text: https://secwatch.observer/filing/0000899923-23-000047.txt

## Key facts
- Debt Financings
  MYRIAD GENETICS INC incurred revolving credit of $90,000,000 with JP Morgan Chase Bank, N.A., as Administrative Agent and as Issuing Bank at ABR plus an applicable margin ranging from 1.00% to 1.50% or Adjusted Term SOFR maturing June 30, 2026.
  - Instrument: revolving credit
  - Principal: $90,000,000
  - Counterparty: JP Morgan Chase Bank, N.A., as Administrative Agent and as Issuing Bank
  - Rate: ABR plus an applicable margin ranging from 1.00% to 1.50% or Adjusted Term SOFR
  - Maturity: June 30, 2026
  - Event: incurrence
  source text: On June 30, 2023 (the "Closing Date"), Myriad Genetics, Inc. (the "Company") entered into a Credit Agreement (the "Credit Agreement") with the lenders from time to time party thereto ("Lenders"), certain of the Company's domestic subsidiaries party thereto (the "Guarantors"), and JP Morgan Chase Bank, N.A., as Administrative Agent (in such capacity, "Administrative Agent") and as Issuing Bank, consisting of a revolving credit facility in an initial maximum principal amount of $90,000,000, with an option to increase the maximum principal amount by up to $25,000,000 (the "Credit Facility").
  evidence_url: https://www.sec.gov/Archives/edgar/data/899923/000089992323000047/0000899923-23-000047-index.htm
- Material Agreements
  MYRIAD GENETICS INC entered into Credit Agreement with JP Morgan Chase Bank, N.A., as Administrative Agent and as Issuing Bank, and the lenders from time to time party thereto valued at $90,000,000 (effective 2023-06-30).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: JP Morgan Chase Bank, N.A., as Administrative Agent and as Issuing Bank, and the lenders from time to time party thereto
  - Value: $90,000,000
  - Effective: 2023-06-30
  source text: On June 30, 2023 (the “Closing Date”), Myriad Genetics, Inc. (the “Company”) entered into a Credit Agreement (the “Credit Agreement”) with the lenders from time to time party thereto (“Lenders”), certain of the Company’s domestic subsidiaries party thereto (the “Guarantors”), and JP Morgan Chase Bank, N.A., as Administrative Agent (in such capacity, “Administrative Agent”) and as Issuing Bank, consisting of a revolving credit facility in an initial maximum principal amount of $90,000,000, with an option to increase the maximum principal amount by up to $25,000,000 (the “Credit Facility”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/899923/000089992323000047/0000899923-23-000047-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.